AIM
LUMO

Acrospire Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Acrospire Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-67
Closed -$11K – 2327
2016
Q1 		$11K Buy
+67
New +$13.6K 0.01% 1732

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Acrospire Investment Management's LUMO Position: Q2 2016 in Review

Acrospire Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 67 shares — an estimated $11K sold.

Acrospire Investment Management first reported a position in LUMO in Q1 2016 and held it in 1 quarter. The position peaked at $11K in Q1 2016. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

  • Acrospire Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 67 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $11K.
  • Acrospire Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $11K in Q1 2016.
  • 112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on Acrospire Investment Management's 13F filing for Q2 2016, filed 9 Aug 2016.